Long-term outcomes in patients younger than 60  years of age treated with brachytherapy for prostate cancer

ConclusionsLDR brachytherapy provides patients younger than 60  years of age with low and intermediate-risk prostate cancer excellent outcomes and has a low risk of significant long-term GU or gastrointestinal morbidity.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research